Otezla (apremilast) is a tablet that's taken by mouth. It's used to treat plaque psoriasis, psoriatic arthritis, and mouth sores from Behçet’s disease. This medication belongs to the drug class called phosphodiesterase-4 (PDE-4) inhibitors. You usually start Otezla (apremilast) at a low dose. Then, the dose is slowly raised over 5 days to lower the risk of side effects like nausea and diarrhea. This medication is available as a brand-name medication. Generic versions of apremilast likely won't be available until at least 2028.
Indications of Taltz vs. Otezla
Indications for
•Moderate-to-severe plaque psoriasis in people ages 6 years and older
•Psoriatic arthritis (PsA) in adults
•Ankylosing spondylitis (AS) in adults
•Non-radiographic axial spondyloarthritis (nr-axSpA) in adults